Suanfarma

Madrid, Spain Founded: 1993 • Age: 33 yrs Acquired By ARCHIMED
Generics, nutraceuticals, and APIs are developed by Suanfarma.

About Suanfarma

Suanfarma is a Healthcare company based in Madrid (Spain) founded in 1993, and was acquired by ARCHIMED in November 2021. Generics, nutraceuticals, and APIs are developed by Suanfarma. The company has 7 employees. Suanfarma has completed 3 acquisitions, including Cidqo, Cipan and Monteloeder. Its Indian entity Indisuan Pharmaceuticals Private Limited reported revenue of β‚Ή31.12 Cr. Suanfarma offers products and services including Active Pharmaceutical Ingredients, CDMO Services, and Intermediate Products. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.

Company details

Suanfarma was founded in 1993 in Madrid, Spain. The company is focused on the pharmaceutical sector, where generics, nutraceuticals, and active pharmaceutical ingredients are developed. Operations encompass research, formulation, and supply chain management for these products. Services are extended to international clients, with primary activities based in Europe. Expansion into global markets has been pursued through partnerships and regulatory compliance.

Key Metrics
  • Indian entity revenue
    ₹31.12 Cr

    FY 2025 · -55% YoY

  • Indian entity net profit
    ₹66.1 Lakh

    FY 2025 · 2% margin

  • Indian entity EBITDA
    ₹2.34 Cr

    FY 2025 · 8% margin

  • Investors
    ICG

    & 2 more

  • Employee Count
    7
  • Investments & Acquisitions
    Cidqo

    & 2 more

  • Acquired by
    ARCHIMED

    & 2 more

    (Nov 2021)

Products & Services of Suanfarma

Suanfarma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, CDMO Services, and Intermediate Products.

Active Pharmaceutical Ingredients
Pharmaceutical Products

High-quality ingredients for human and veterinary drug manufacturing.

CDMO Services
Contract Manufacturing

Integrated end-to-end solutions for pharmaceutical development and production.

Intermediate Products
Chemical Intermediates

Raw materials used in pharmaceutical ingredient synthesis.

Apps and channels of Suanfarma

its YouTube channel Suanfarma has 51 subscribers and 7 videos.

Suanfarma
YouTube 51 subscribers 7 videos Science & Technology
Open channel

Videos from Suanfarma

The most watched videos on Suanfarma's YouTube channel, Suanfarma (51 subscribers). Click a video to play it here.

Suanfarma CDMO - Cipan
1.5K views
Suanfarma at a Glance
868 views
Suanfarma CDMO: Advancing a Healthier Future
399 views
Suanfarma, At the Core of a Better Life
327 views

More on Suanfarma.

Investors in Suanfarma

Suanfarma has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include ICG, ProA Capital and ARCHIMED.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
proacapital.com
ICG is recognized as a global alternative asset manager.
1989icgam.comLondon, United Kingdom
Healthcare industries are funded and supported globally by ARCHIMED.
archimed.groupLyon, France
Premium access

Investor details for Suanfarma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Indisuan Pharmaceuticals Private Limited (Suanfarma)

Indisuan Pharmaceuticals Private Limited is the primary company behind Suanfarma. The board of Indisuan Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Jawed Zia, appointed in 2025. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jawed Zia
DIN 00191276
Additional Director31 Jan 20251 yr 9 moIndisuan Pharmaceuticals Private Limited
Amol Pramod Salvi
DIN 11044007
Additional Director07 Apr 20251 yr 7 moIndisuan Pharmaceuticals Private Limited

Financials of Suanfarma

Figures of Indisuan Pharmaceuticals Private Limited, the primary company behind Suanfarma, for FY 2025. Revenue was ₹31.12 Cr (-55% year on year). Net profit was ₹66.1 Lakh (2% margin). EBITDA was ₹2.34 Cr (8% margin). Revenue has grown at a compounded annual rate of -13% over three years and -3% over five years.

  • ₹31.12 CrRevenue · FY 2025 · -55% YoY
  • ₹66.1 LakhNet profit · 2% margin
  • ₹2.34 CrEBITDA · 8% margin
  • ₹10 LakhPaid-up capital
  • 7Employees (provident fund records)
  • -13%Revenue CAGR, 3 years
  • -3%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Indisuan Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Suanfarma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Suanfarma

Suanfarma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cidqo, Cipan and Monteloeder.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Nutraceutical ingredients are supplied for supplements, cosmetics, and nutrition.
monteloeder.comElche, Spain1996Feb 2022β€’β€’β€’β€’
Antibiotic-based Active Pharmaceutical Ingredients and Intermediates are developed and manufactured.
cipan.ptCastanheira Do Ribatejo, Portugal1960Sep 2016β€’β€’β€’β€’
Pharmaceuticals and intermediates are developed using combinatorial chemistry.
cidqo.comBarcelona, Spain2012Mar 2013β€’β€’β€’β€’
Premium access

Complete acquisition details for Suanfarma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Suanfarma

7 dated milestones of Suanfarma across 29 years, from founding to its latest funding, stage changes and deals.

  1. Founded Suanfarma is founded.
  2. Acquisition Acquires Cidqo.
  3. Exit Acquired by ProA Capital.
  4. Acquisition Acquires Cipan.
  5. Exit Acquired by ICG.
  6. Exit Acquired by ARCHIMED.
  7. Acquisition Acquires Monteloeder.

Web traffic of Suanfarma

The website of Suanfarma (suanfarma.com) receives about 7.4K visits a month and ranks #3,394,565 among all websites worldwide, #4,442 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    7.4K

    ▲ 40.9% vs previous month

  • Unique visitors
    2.2K

    per month

  • Global rank
    #3,394,565

    among all websites

  • Category rank
    #4,442

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Suanfarma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
artsenbezoeker.vacatures-stoevelaar.com
artsenbezoeker.vacatures-stoevelaar.com
100%
–
completfarma.com
completfarma.com
62%
–
heberfarma.com
heberfarma.com
62%
#4,788,925–
mapbiopharma.es
mapbiopharma.es
36%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Suanfarma

Premium access

Complete news archive for Suanfarma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suanfarma

Suanfarma was founded in 1993.

Suanfarma is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.

Suanfarma has 7 employees.

The primary company behind Suanfarma, Indisuan Pharmaceuticals Private Limited, reported revenue of β‚Ή31.12 Cr for FY 2025, down 55% year on year.

Suanfarma was founded in 1993 in Madrid, Spain. The company is focused on the pharmaceutical sector, where generics, nutraceuticals, and active pharmaceutical ingredients are developed. Operations encompass research, formulation, and supply chain management for these products. Services are extended to international clients, with primary activities based in Europe. Expansion into global markets has been pursued through partnerships and regulatory compliance.

Suanfarma offers Active Pharmaceutical Ingredients, CDMO Services, and Intermediate Products.

Suanfarma has made 3 acquisitions, including Cidqo, Cipan, and Monteloeder.

Suanfarma has 3 investors. Key investors include ICG, ProA Capital, and ARCHIMED.

Suanfarma operates through Indisuan Pharmaceuticals Private Limited.

Yes. Suanfarma was acquired by ARCHIMED in November 2021.

The legal entities of Suanfarma currently have 2 directors, including Jawed Zia, Amol Pramod Salvi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available